JASPER THERAPEUTICS INC - COM (JSPR)

CUSIP: 471871103

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM
Total 13F shares
91,546,422
Share change
+3,464,917
Total reported value
$63,736,433
Put/Call ratio
0.15%
Price per share
$0.70
Number of holders
39
Value change
+$1,326,196
Number of buys
17
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 471871103?
CUSIP 471871103 identifies JSPR - JASPER THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of JASPER THERAPEUTICS INC - COM (JSPR) as of Q3 2023

As of 30 Sep 2023, JASPER THERAPEUTICS INC - COM (JSPR) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 91,546,422 shares. The largest 10 holders included Velan Capital Investment Management LP, BVF INC/IL, Carlyle Group Inc., Qiming U.S. Ventures Management, LLC, Soleus Capital Management, L.P., SPHERA FUNDS MANAGEMENT LTD., FRANKLIN RESOURCES INC, Octagon Capital Advisors LP, VANGUARD GROUP INC, and BANK OF AMERICA CORP /DE/. This page lists 39 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.